Abstract
A prototypical patient is presented to introduce important design issues for clinical trials of antibacterials in the treatment of hospital-acquired bacterial pneumonia.
MeSH terms
-
Aged
-
Anti-Bacterial Agents / therapeutic use*
-
Clinical Trials as Topic*
-
Cross Infection / drug therapy*
-
Cross Infection / microbiology
-
Humans
-
Male
-
Pneumonia, Bacterial / drug therapy*
-
Pneumonia, Bacterial / microbiology
-
Treatment Outcome